Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nature Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling” that was published by Springer in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Can GPCRs be targeted to control inflammation in asthma?.- 2. Cellular and molecular processes in pulmonary hypertension.- 3. INFLAMMATORY PATHWAYS IN SARCOIDOSIS.- 4. Innate Immune Responses and Pulmonary Diseases.- 5. Interstitial Lung Disease associated with Connective Tissue Diseases.- 6. Molecular mechanisms of vascular damage during lung injury.- 7. Neurotrophin Regulation and Signaling in Airway Smooth Muscle.- 8. Novel Thoracic MRI approaches for the assessment of pulmonary physiology and inflammation.- 9. Overview on Interactive Role of Inflammation, Reactive Oxygen Species and Calcium signaling in Asthma, COPD and Pulmonary Hypertension.- 10. Protein S-palmitoylation and lung diseases.- 11. Redox role of ROS and inflammation in pulmonary diseases.- 12. Semaphorin3E/PlexinD1 axis in asthma: what we know so far.- 13. Serine protease inhibitors to treat lung inflammatory diseases.- 14. Sex and Gender Differences in Lung Disease.- 15. Sex hormones and lung inflammation.- 16. Synopsis of Clinical Acute Respiratory Distress Syndrome (ARDS)

Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nature Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling” that was published by Springer in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Can GPCRs be targeted to control inflammation in asthma?.- 2. Cellular and molecular processes in pulmonary hypertension.- 3. INFLAMMATORY PATHWAYS IN SARCOIDOSIS.- 4. Innate Immune Responses and Pulmonary Diseases.- 5. Interstitial Lung Disease associated with Connective Tissue Diseases.- 6. Molecular mechanisms of vascular damage during lung injury.- 7. Neurotrophin Regulation and Signaling in Airway Smooth Muscle.- 8. Novel Thoracic MRI approaches for the assessment of pulmonary physiology and inflammation.- 9. Overview on Interactive Role of Inflammation, Reactive Oxygen Species and Calcium signaling in Asthma, COPD and Pulmonary Hypertension.- 10. Protein S-palmitoylation and lung diseases.- 11. Redox role of ROS and inflammation in pulmonary diseases.- 12. Semaphorin3E/PlexinD1 axis in asthma: what we know so far.- 13. Serine protease inhibitors to treat lung inflammatory diseases.- 14. Sex and Gender Differences in Lung Disease.- 15. Sex hormones and lung inflammation.- 16. Synopsis of Clinical Acute Respiratory Distress Syndrome (ARDS)

Dr. Yong-Xiao Wang is a Full Professor in the Department of Molecular and Cellular Physiology at Albany Medical College, Albany, New York, USA. He received his M.D. at the Wannan Medical College (China), Ph.D. at the Fourth Military Medical University (China), and postdoctoral training at the Technical University of Munich (Germany) as well as the University of Pennsylvania (USA). Dr. Wang’s primary research interests have focused on basic, translational, and drug discovery research concerning cardiac arrhythmias and hypertrophy, pulmonary hypertension, asthma, and diabetes for over 30 years. In particular, he has had extensive research experience in the studies of the molecular geneses, regulatory mechanisms, network pathways, physiological functions, and the critical roles of calcium, redox, inflammatory, and other signaling in the aforementioned illnesses. Dr. Wang has been the corresponding author, first author, and key contributor in numerous publications in highly peer-reviewed journals including Nature Commun, Antioxid Redox Signal, Proc Natl Acad Sci USA, Free Radic Biol Med, Cell Calcium, J Gen Physiol, J Biol Chem, FASEB J, Nature, Circ Res, and more. He has been the editor of several academic books in the field including a recent one entitled “Pulmonary Vasculature Redox Signaling” that was published by Springer in 2017. Dr. Wang has been the principal investigator on multiple research grants and awards from the National Institutes of Health, American Heart Association, American Diabetes Association, and other agencies. He has collaborated with numerous well-known scientists, served on various grant review panels, been the Editor-In-Chief and Editorial Board Member for several scientific journals, and trained a number of scholars, some of whom have become well-known independent investigators in the field.

• 1. Can GPCRs be targeted to control inflammation in asthma?.- 2. Cellular and molecular processes in pulmonary hypertension.- 3. INFLAMMATORY PATHWAYS IN SARCOIDOSIS.- 4. Innate Immune Responses and Pulmonary Diseases.- 5. Interstitial Lung Disease associated with Connective Tissue Diseases.- 6. Molecular mechanisms of vascular damage during lung injury.- 7. Neurotrophin Regulation and Signaling in Airway Smooth Muscle.- 8. Novel Thoracic MRI approaches for the assessment of pulmonary physiology and inflammation.- 9. Overview on Interactive Role of Inflammation, Reactive Oxygen Species and Calcium signaling in Asthma, COPD and Pulmonary Hypertension.- 10. Protein S-palmitoylation and lung diseases.- 11. Redox role of ROS and inflammation in pulmonary diseases.- 12. Semaphorin3E/PlexinD1 axis in asthma: what we know so far.- 13. Serine protease inhibitors to treat lung inflammatory diseases.- 14. Sex and Gender Differences in Lung Disease.- 15. Sex hormones and lung inflammation.- 16. Synopsis of Clinical Acute Respiratory Distress Syndrome (ARDS)